SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.230
-0.120 (-8.87%)
At close: Apr 1, 2025, 4:00 PM
1.279
+0.049 (3.99%)
After-hours: Apr 1, 2025, 7:58 PM EDT

SAB Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-34.11-42.19-18.74-17.1420.12
Upgrade
Depreciation & Amortization
4.793.753.291.650.55
Upgrade
Loss (Gain) From Sale of Assets
-0.04-0.02-0.01-0
Upgrade
Stock-Based Compensation
2.942.422.672.311.3
Upgrade
Other Operating Activities
-5.628.53-10.433.49-
Upgrade
Change in Accounts Receivable
-5.562.4512.56-17.75
Upgrade
Change in Accounts Payable
0.92-2.7-0.78-2.945.21
Upgrade
Change in Unearned Revenue
-1.321.32-0.1-0.1
Upgrade
Change in Other Net Operating Assets
-1.9-1.85-1.812.060.48
Upgrade
Operating Cash Flow
-34.29-25.12-23.461.9910
Upgrade
Operating Cash Flow Growth
----80.14%-
Upgrade
Capital Expenditures
-0.34-0.2-2.17-10.94-12.73
Upgrade
Sale of Property, Plant & Equipment
-0.040.08-0.01
Upgrade
Investment in Securities
-11.63----
Upgrade
Investing Cash Flow
-11.96-0.15-2.09-10.94-12.72
Upgrade
Long-Term Debt Issued
0.520.771.242.840.66
Upgrade
Short-Term Debt Repaid
-----1.36
Upgrade
Long-Term Debt Repaid
-1.42-1.16-2.42-1.3-0.21
Upgrade
Total Debt Repaid
-1.42-1.16-2.42-1.3-1.58
Upgrade
Net Debt Issued (Repaid)
-0.91-0.39-1.191.54-0.92
Upgrade
Issuance of Common Stock
0.0259.667.760.019.9
Upgrade
Repurchase of Common Stock
-0.02----
Upgrade
Other Financing Activities
-0.26--5.5234.34-
Upgrade
Financing Cash Flow
-1.1766.771.0535.898.98
Upgrade
Foreign Exchange Rate Adjustments
-0.240.02---
Upgrade
Net Cash Flow
-47.6741.52-24.526.936.26
Upgrade
Free Cash Flow
-34.63-25.32-25.63-8.96-2.73
Upgrade
Free Cash Flow Margin
-2618.65%-1130.71%-107.20%-14.71%-4.94%
Upgrade
Free Cash Flow Per Share
-3.74-4.58-5.89-3.28-1.01
Upgrade
Cash Interest Paid
-0.250.29--
Upgrade
Cash Income Tax Paid
--0.03--
Upgrade
Levered Free Cash Flow
-25.05-17.95-14.293.28-10.5
Upgrade
Unlevered Free Cash Flow
-24.85-17.75-14.13.46-10.21
Upgrade
Change in Net Working Capital
2.48-0.07-0.18-18.8112.17
Upgrade
Updated Nov 6, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q